Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial is a research paper published in Clinical Microbiology and Infection (2025). On theSindex it has a DataRank of 0.204. It has been cited 2 times, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0.0393
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
NIAID
Grant: 75N91019D00024
NIAID
Grant: 75N91020F00014
NIAID
Grant: 75N91020F00039
NIH
Grant: 1OT2HL156812-01
ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating Center
NHLBI NIH HHS
Grant: OT2 HL156812
AstraZeneca
National Cancer Institute
Pfizer
FWCI
1.56
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords